Pharmaceuticals: Canada Industry Guide is an essential resource for top-level data and analysis covering the Canada Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
* The Canadian biotechnology market grew by 5.0% in 2007 to reach a value of $4,321 million.
* The Canadian generics market generated total revenues of $3.5 billion in 2007, representing a compound annual growth rate (CAGR) of 10.7% for the period spanning 2003-2007.
* The Canadian OTC pharmaceuticals market generated total revenues of $2.3 billion in 2008, representing a compound annual growth rate (CAGR) of 3.5% for the period spanning 2004-2008.
* Canadian pharmaceutical market generated total revenues of $24.2 billion in 2008, representing a compound annual growth rate (CAGR) of 6.6% for the period spanning 2004-2008.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
CHAPTER 1 BIOTECHNOLOGY IN CANADA 10
1.1 Market Overview 10
1.2 Market Value 12
1.3 Market Segmentation I 13
1.4 Market Segmentation II 14
1.5 Five Forces Analysis 15
1.6 Market Forecasts 21
CHAPTER 2 GENERICS IN CANADA 22
2.1 Market Overview 22
2.2 Market Value 24
2.3 Market Segmentation I 25
2.4 Market Segmentation II 26
2.5 Five Forces Analysis 27
2.6 Market Forecasts 34
CHAPTER 3 OTC PHARMACEUTICALS IN CANADA 35
3.1 Market Overview 35
3.2 Market Value 37
3.3 Market Segmentation I 38
3.4 Market Segmentation II 39
3.5 Market Share 40
3.6 Five Forces Analysis 41
3.7 Market Forecasts 47
CHAPTER 4 PHARMACEUTICALS IN CANADA 48
4.1 Market Overview 48
4.2 Market Value 50
4.3 Market Segmentation I 51
4.4 Market Segmentation II 52
4.5 Market Share 53
4.6 Five Forces Analysis 54
4.7 Market Forecasts 61
CHAPTER 5 DEMOGRAPHICS 62
CHAPTER 6 APPENDIX 64
6.1 Data Research Methodology 64
LIST OF TABLES
Table 1: Canada Biotechnology Market Value: $ million, 2003-2007 12
Table 2: Canada Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Table 3: Canada Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Table 4: Canada Biotechnology Market Value Forecast: $ million, 2007-2012 21
Table 5: Canada Generics Market Value: $ billion, 2003-2007 24
Table 6: Canada Generics Market Segmentation I: % Share, by Value, 2007 25
Table 7: Canada Generics Market Segmentation II: % Share, by Value, 2007 26
Table 8: Canada Generics Market Value Forecast: $ billion, 2007-2012 34
Table 9: Canada OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 37
Table 10: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Table 11: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Table 12: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Table 13: Canada OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 47
Table 14: Canada Pharmaceuticals Market Value: $ million, 2003-2007 50
Table 15: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 51
Table 16: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 52
Table 17: Canada Pharmaceuticals Market Share: % Share, by Value, 2007 53
Table 18: Canada Pharmaceuticals Market Value Forecast: $ million, 2007-2012 61
Table 19: Canada Size of Population (million) , 2003-2007 62
Table 20: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007 62
Table 21: Canada Inflation, 2003-2007 62
Table 22: Canada Exchange Rate, 2003 63
LIST OF FIGURES
Figure 1: Canada Biotechnology Market Value: $ million, 2003-2007 12
Figure 2: Canada Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Figure 3: Canada Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Figure 4: Forces Driving Competition in the Biotechnology Market in Canada, 2007 15
Figure 5: Drivers of Buyer Power in the Biotechnology Market in Canada, 2007 16
Figure 6: Drivers of Supplier Power in the Biotechnology Market in Canada, 2007 17
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Canada, 2007 18
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Canada, 2007 19
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in Canada, 2007 20
Figure 10: Canada Biotechnology Market Value Forecast: $ million, 2007-2012 21
Figure 11: Canada Generics Market Value: $ billion, 2003-2007 24
Figure 12: Canada Generics Market Segmentation I: % Share, by Value, 2007 25
Figure 13: Canada Generics Market Segmentation II: % Share, by Value, 2007 26
Figure 14: Forces Driving Competition in the Generics Market in Canada, 2007 27
Figure 15: Drivers of Buyer Power in the Generics Market in Canada, 2007 29
Figure 16: Drivers of Supplier Power in the Generics Market in Canada, 2007 30
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in Canada, 2007 31
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in Canada, 2007 32
Figure 19: Drivers of Degree of Rivalry in the Generics Market in Canada, 2007 33
Figure 20: Canada Generics Market Value Forecast: $ billion, 2007-2012 34
Figure 21: Canada OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 37
Figure 22: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Figure 23: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Figure 24: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in Canada 41
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Canada 42
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Canada 43
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Canada 44
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Canada 45
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Canada 46
Figure 31: Canada OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 47
Figure 32: Canada Pharmaceuticals Market Value: $ million, 2003-2007 50
Figure 33: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 51
Figure 34: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 52
Figure 35: Canada Pharmaceuticals Market Share: % Share, by Value, 2007 53
Figure 36: Forces Driving Competition in the Pharmaceuticals Market in Canada, 2007 54
Figure 37: Drivers of Buyer Power in the Pharmaceuticals Market in Canada, 2007 55
Figure 38: Drivers of Supplier Power in the Pharmaceuticals Market in Canada, 2007 56
Figure 39: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Canada, 2007 58
Figure 40: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Canada, 2007 59
Figure 41: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Canada, 2007 60
Figure 42: Canada Pharmaceuticals Market Value Forecast: $ million, 2007-2012 61
Other selected research from the 'Canada' category:
OTC Pharmaceuticals - North America (NAFTA) Industry Guide
Pharmaceuticals in Canada
Other selected research from the 'Markets' category:
Partneringreview 2006 Vol 4 Ch 2: Clinical stage: phase I to phase III (PR06V4C02)
Partneringreview 2006 - Industry sector (volume 6)